颅内肿瘤放射治疗后<sup>18</sup>F-氟代脱氧葡萄糖PET的临床意义

陈跃

颅内肿瘤放射治疗后¹⁸F-氟代脱氧葡萄糖PET的临床意义

陈跃

文章导航 > 国际放射医学核医学杂志 > 2006, 30 > 2: (97-99)

引用本文:

Citation:

颅内肿瘤放射治疗后¹⁸F-氟代脱氧葡萄糖PET的临床意义

陈跃

646000 四川, 泸州医学院附属医院核医学科
中图分类号: R817.4

Clinical value of ¹⁸F-FDG PET after radiotherapy for intracerebral tumors

CHEN Yue

Department of Nuclear Medicine, Luzhou Medical College Hospital, Sichuan Luzhou 646000, China
CLC number: R817.4

摘要: 放射治疗是颅内良恶性肿瘤安全有效的治疗方法,¹⁸F-FDG PET可以提供肿瘤细胞生物特性信息,能区分颅内肿瘤放射治疗后射线损伤与肿瘤复发,灵敏度为80%-90%,特异度为40%~100%;能预测3~4级复发恶性胶质瘤放射治疗的生存时间,预测颅内肿瘤放射治疗预后和评价治疗反应;结合其他影像方法可提高颅内肿瘤放射治疗诊断准确性。
- ¹⁸F-氟脱氧葡萄糖 /
- 体层摄影术,发射型计算机 /
- 脑肿瘤 /
- 放射疗法
Abstract: Radiotherapy is a safe and effective management strategy for a variety of intracerebral tumors. ¹⁸F-FDG PET can provide information about the biologic characteristics of malignant cells and differentiate recurrent tumor from radiation necrosis, the sensitivity and specificity of FDG PET is 80% to 90% and 40% to 100%. ¹⁸F-FDG PET can predict the survival in high-grade recurrent gloima. The diagnostic and prognostic information can be provided by ¹⁸F-FDG PET. Co-registration of MRI or CT on a single computer may improve diagnostic accuracy of PET after radiotherapy for intracerebral tumors.
- ¹⁸F-fluorodeoxyglucose /
- Tomography,emission computed /
- Brain tumors /
- Radiotherapy
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Siepmann DB,Siegel A,Lewis PJ.Tl-201 SPECT and ¹⁸F-FDG PET for assessment of glioma recurrence versus radiation necrosis.Clin Nucl Med,2005,30(3):199-200.
[2]	Lichy MP,Bachert P,Henze M,et al.Monitoring individual response to brain-tumour chemotherapy:proton MR spectroscopy in a patient with recurrent glioma after stereotactic radiotherapy.Neuroradiology.2004,46(2):126-129.
[3]	Levivier M,Massager N,Wikler D,et al.Modern multimodal neuroimaging for radiosurgery:the example of PET scan integration.Acta Neurochir Suppl,2004,91:1-7.
[4]	Raman A,Rothrock JF,Liu HG,et al.Differentiation of benign vs.malignant mass in a postirradiation cerebral arteriovenous malformation by 2-deoxy-2-[¹⁸F] fluoro-D-glucose positron emission tomography.Mol Imaging Biol,2004,6(1):1-6.
[5]	Lee JK,Liu RS,Shiang HR,et al.Usefulness of semiquantitative ¹⁸F-FDG PET in the prediction of brain tumor treatment response to gamma knife radiosurgery.J Comput Assist Tomogr,2003,27(4):525-529.
[6]	Wong TZ,van der Westhuizen GJ,Coleman RE.PET imaging of brain tumors.Neuroimag Clin N Am,2002,12(4):615-626.
[7]	Di Chiro G,Oldfield E,Wright DC,et al.Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors:PET and neuropathologic studies.Am J Roentgenol,1988,150(1):189-197.
[8]	Langleben DD,Segall GM.PET in differentiation of recurrent brain tumor from radiation injury.J Nucl Med,2000,41(11):1861-1867.
[9]	Kim EE,Chung SK,Haynie TP,et al.Differentiation of residual or recurrent tumors from post-treatment changes with ¹⁸F-FDG PET.Radiographics,1999,12(2):269-279.
[10]	Ricci PE,Karis JP,Heiserman JE,et al.Differentiating recurrent tumor from radiation necrosis:time for re-evaluation of positron emission tomography? Am J Neuroradiol,1998,19(3):407-413
[11]	Kresnik E,Mikosch P,Gallowitsch HJ,et al.Evaluation of head and neck cancer with ¹⁸F-FDG PET:a comparison with conventional methods.EurJ Nucl Med,2001,28(7):816-821
[12]	Chao ST,Suh JH,Raja S,et al.The sensitivity and specificity of ¹⁸F-FDG PET in distinguishing rec urrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery.Int J Cancer,2001,96(3):191-197.

[1]	黄喆敏 , 左传涛 , 管一晖 . ¹⁸F-氟脱氧葡萄糖的脑肿瘤PET. 国际放射医学核医学杂志, 2007, 31(3): 163-165,172.
[2]	邓大平 , 卢峰 , 孙洪强 , 魏玮 , 姜玉华 . 颅脑肿瘤放射治疗时射野外器官吸收剂量体模法测量与分析. 国际放射医学核医学杂志, 2016, 40(4): 272-276. doi: 10.3760/cma.j.issn.1673-4114.2016.04.007
[3]	宋少莉 , 黄钢 . ¹⁸F-氟脱氧葡萄糖PET监测实体瘤放化疗疗效的应用进展. 国际放射医学核医学杂志, 2007, 31(5): 284-288.
[4]	吕慧清 , 张中民 , 吕仲虹 . ¹⁸F-氟代脱氧葡萄糖PET在恶性肿瘤适形放射治疗中的价值. 国际放射医学核医学杂志, 2006, 30(6): 335-337.
[5]	蔡莉 , 李彦生 . 氟代脱氧葡萄糖与氨基酸PET在脑肿瘤中的对比研究. 国际放射医学核医学杂志, 2005, 29(1): 10-14.
[6]	夏伟 , 罗全勇 , 袁志斌 . PET-CT在肿瘤放射治疗中的应用. 国际放射医学核医学杂志, 2006, 30(6): 331-335.
[7]	王俊起 , 高硕 . PET评价骨转移瘤. 国际放射医学核医学杂志, 2006, 30(2): 87-90.
[8]	李亚军 , 白人驹 , 高硕 . PET在前列腺癌中的应用. 国际放射医学核医学杂志, 2006, 30(5): 283-286.
[9]	陈艳芳 , 杨天恩 , 曹永珍 . 放射性脑损伤和脑肿瘤复发的鉴别诊断. 国际放射医学核医学杂志, 2006, 30(5): 308-311.
[10]	陈洪雷 , 张可领 . 脑肿瘤的组织间近距离放射治疗. 国际放射医学核医学杂志, 2004, 28(1): 18-21.

点击查看大图

计量

文章访问数: 1149
HTML全文浏览量: 85
PDF下载量: 2

颅内肿瘤放射治疗后¹⁸F-氟代脱氧葡萄糖PET的临床意义

陈跃

646000 四川, 泸州医学院附属医院核医学科

收稿日期: 2005-04-22

关键词:

摘要: 放射治疗是颅内良恶性肿瘤安全有效的治疗方法,¹⁸F-FDG PET可以提供肿瘤细胞生物特性信息,能区分颅内肿瘤放射治疗后射线损伤与肿瘤复发,灵敏度为80%-90%,特异度为40%~100%;能预测3~4级复发恶性胶质瘤放射治疗的生存时间,预测颅内肿瘤放射治疗预后和评价治疗反应;结合其他影像方法可提高颅内肿瘤放射治疗诊断准确性。